Clinical Trial Update: A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the cardiac safety of multiple doses of BI 456906 in adults with overweight or obesity. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• BI 456906

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED